Senior Principal Scientist, Oncology Imaging Strategy

Lantheus; Bedford (MA); On-site; USD 172,000 - 287,000; Full time

Job summary

Lantheus in Bedford, MA is seeking a Clinical Research, Senior Principal Scientist, Oncology to provide strategic and scientific leadership for oncology clinical development, with emphasis on diagnostic imaging and radiopharmaceuticals. The role partners with the Executive Director and works across cross-functional teams.

Based in Bedford with on-site presence two to three days per week, the role supports governance, regulatory interactions and external scientific forums, shaping asset and

Qualifications

• Advanced degree in oncology, medicine, pharmaceutical sciences, molecular biology, imaging sciences or related field.
• 10+ years of experience in pharmaceutical/biotech radiopharmaceuticals or clinical research with oncology focus.
• Expertise in clinical trial design, execution, data interpretation and development strategy across multiple phases.

Responsibilities

• Serve as scientific lead for oncology diagnostic development programs across Phase I–IV studies.
• Develop and refine development strategies, target product profiles, study concepts and endpoints.
• Lead interpretation of company-sponsored oncologic research, including imaging endpoints and biomarkers.

Skills

Clinical trial design

Oncology diagnostics

Imaging sciences

Cross-functional leadership

Regulatory knowledge

Written communication

Verbal communication

Scientific leadership

Strategic thinking

Travel flexibility

Education

PhD/MD/PharmD or equivalent

Job description

Lantheus in Bedford, MA is seeking a Clinical Research, Senior Principal Scientist, Oncology to provide strategic and scientific leadership for oncology clinical development, with emphasis on diagnostic imaging and radiopharmaceuticals. The role partners with the Executive Director and works across cross-functional teams.

Based in Bedford with on-site presence two to three days per week, the role supports governance, regulatory interactions and external scientific forums, shaping asset and